Joelf Posted October 10, 2020 Share Posted October 10, 2020 Machine learning predicts stem cell transplant (HSCT) response in severe scleroderma (SSc). This study suggests that intrinsic subset stratification of patients may be used to identify patients with SSc who receive significant benefit from HSCT. PubMed, Ann rheumatologist Dis, 2020 Sep 15;annrheumdis-2020-217033. (Also see Stem Cell Transplantation) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles. Quote Link to post Share on other sites
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.